1-3 of 3
Nancy Delgado-López
Close
Sort by
Journal Articles

The Impact of Adding Rituximab to the Standard Chemotherapy + TKI Regimen in Adults with Philadelphia-Positive B Acute Lymphoblastic Leukemia: A Multicenter Retrospective Study

Sergio Rodriguez-Rodriguez, Fausto Alfredo Rios Olais, Analy Mora, Christian Omar Ramos Peñafiel, Victor Itaí Urbalejo Ceniceros, Yadith Karina Lopez-Garcia, Andres Gomez-De Leon, Nancy Delgado-López, Mistral Castellanos Mares, Patricia Carolina Figueroa Hernandez, Roberta Demichelis
Journal: Blood
Blood (2023) 142 (Supplement 1): 4204.
https://doi.org/10.1182/blood-2023-186378
Published: 2023
Journal Articles

Molecular Status Evaluation in a Standardized Laboratory in a Cohort of Patients with Chronic Myeloid Leukemia At the Instituto Mexicano Del Seguro Social (IMSS)

Luis A Meillón, MD, Carolina Sandoval-Sanchez, PhD, Nancy Delgado-Lopez, MD, Manuel Ayala, MD, Yolanda Lugo, Maria Mora, MD, Noe Diaz-Robles, MD, Patricia Oropeza, MD, Angelica Romo, MD, Kevin Nacho-Vargas, MD
Journal: Blood
Blood (2012) 120 (21): 4452.
https://doi.org/10.1182/blood.V120.21.4452.4452
Published: 2012
Journal Articles

Imatinib Mesylate (IM) Versus IM + Low Dose of Pegylated Interferon Alfa 2a (Peg-IFN 2a) In Newly-Diagnosed Chronic-Phase (CP) Chronic Myeloid Leukemia (CML).

Luis Antonio Meillon, MD, Salvador Campos-Cabrera, Nancy Delgado-Lopez, Angel A. Fernandez-Martinez, Jesus Medrano-Contreras, Guillermo Gutierrez, MD, Juan F. Perez-Rocha, Eduardo Terreros-Muñoz, Sue C. Gomez-Cortes, Susana Guerrero-Rivera, Kevin A. Nacho-Vargas, MD
Journal: Blood
Blood (2010) 116 (21): 4497.
https://doi.org/10.1182/blood.V116.21.4497.4497
Published: 2010